Press release
Shedding Light on the Desmoid Tumors Market: Exploring Market Size, Demand Trends, and Emerging Treatment Options || Pfizer Inc., F.Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG
Desmoid Tumors Market
The Business Research Company offers in-depth market insights through Desmoid Tumors Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The desmoid tumors market size has grown strongly in recent years. It will grow from $2.76 billion in 2023 to $2.97 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to advancements in medical imaging, genetic research and understanding, surgical innovations, awareness and education, patient advocacy.
The desmoid tumors market size is expected to see strong growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to targeted therapies, personalized medicine, expanded international collaborations, regulatory approvals for novel therapies, patient-centric approaches. Major trends in the forecast period include advancements in treatment approaches, precision medicine and biomarker discovery, clinical trials and research initiatives, multidisciplinary treatment teams, patient advocacy and support.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13228&type=smp
Market Segmentation:
The desmoid tumors market covered in this report is segmented -
1) By Treatment: Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments
2) By Diagnosis: Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis
3) By End-User: Hospitals And Clinics, Specialty Centers, Other End-Users
Major Driver - Rising Global Cancer Incidence Fuels Growth In The Desmoid Tumor Market
The rising cases of cancer are expected to propel the growth of the desmoid tumor market going forward. Cancer refers to a collection of disorders that are defined by the body's aberrant cells growing and spreading out of control. These cells can infiltrate nearby tissues and organs and cause harm. The rising cancer cases worldwide have fueled the demand for effective and advanced chemotherapeutic agents, positively influencing the desmoid tumor market. For instance, in January 2023, according to reports published by the American Cancer Society Inc., a US-based voluntary health organization, 1.8 million new cancer cases were diagnosed in the US in 2020, and 606,520 cancer fatalities. By 2021, it was projected that the number of new cancer cases diagnosed would rise to 1.9 million, and the number of cancer deaths would increase to 608,570. Therefore, the rising cases of cancer are driving the growth of the desmoid tumor market.
Competitive Landscape:
Major companies operating in the desmoid tumors market report are Pfizer Inc., F.Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG, Novartis AG, Abbott Laboratories, Amgen Inc., Stryker Corporation, Genome And Company , Vertex Pharmaceuticals Incorporated, Eisai Limited, Beckman Coulter Inc., Incyte Corporation , Ipsen Biopharmaceuticals Inc., BeiGene Ltd., Janssen Biotech Inc., Ionis Pharmaceuticals Inc., Ayala Pharmaceuticals Inc., Blueprint Medicines Corporation, Xencor Inc., MacroGenics Inc., Debiopharm Group, Clovis Oncology Inc., Juno Therapeutics Inc., SpringWorks Therapeutics Inc., Loxo Oncology Inc., Mirati Therapeutics Inc., Iterion Therapeutics Inc., Recepta Pharmaceuticals Inc., Cellestia Biotech AG
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report
Top Trend - Increasing Focus On Drug Developments To Drive The Revenues
Major companies operating in the desmoid tumors market are developing innovative drugs such as nirogacestat for the treatment of desmoid tumors to meet the needs of their existing consumers better. Nirogacestat is an oral, small-molecule gamma-secretase inhibitor. For instance, in February 2023, SpringWorks Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, announced a U.S. Food and Drug Administration (FDA) acceptance and priority review of their new drug application (NDA) for nirogacestat for the treatment of adults with desmoid tumors. Nirogacestat is thought to work by blocking the production of notch proteins, which can lead to the death of tumor cells. Desmoid tumors produce high levels of notch protein, which is thought to contribute to their growth. Moreover, nirogacestat provides patients with a new treatment option that can potentially improve outcomes.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Desmoid Tumors Market Characteristics
3. Desmoid Tumors Market Trends And Strategies
4. Desmoid Tumors Market - Macro Economic Scenario
5. Desmoid Tumors Market Size And Growth
…..
27. Desmoid Tumors Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Shedding Light on the Desmoid Tumors Market: Exploring Market Size, Demand Trends, and Emerging Treatment Options || Pfizer Inc., F.Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG here
News-ID: 3436718 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Desmoid
Desmoid Tumors Market Future Business Scope Analysis Report, Marketing Strategy, …
Introduction
The Desmoid Tumors Market focuses on a rare, locally aggressive, but non-metastatic type of soft tissue tumor that arises from fibroblasts. Also known as aggressive fibromatosis, desmoid tumors can occur anywhere in the body, but are most common in the abdomen, shoulder, and limbs. Although they do not spread to distant organs, they can cause significant morbidity due to local invasion and recurrence.
Over the past decade, treatment strategies have evolved…
Desmoid Tumors Market Poised for 6.8 % Growth, Set to Hit $4.13 Billion by 2029
How Are the key drivers contributing to the expansion of the desmoid tumors market?
The escalating prevalence of cancer is predicted to catalyze the expansion of the desmoid tumor market. Cancer is characterized by abnormal cellular growth in the body, which can uncontrollably spread and potentially damage nearby tissues and organs. With global cancer rates climbing, there has been a corresponding surge in demand for refined chemotherapeutic agents, having a favorable…
Top Factor Driving Desmoid Tumors Market Growth in 2025: Rising Global Cancer In …
How Big Is the Desmoid Tumors Market Expected to Be, and What Will Its Growth Rate Be?
The desmoid tumors market is set to grow from $2.97 billion in 2024 to $3.18 billion in 2025, at a CAGR of 7.3%. Growth is driven by advancements in medical imaging, genetic research, surgical innovations, and increased awareness and education on these tumors.
The desmoid tumors market is forecast to grow strongly, reaching $4.13 billion…
Top Factor Driving Desmoid Tumors Market Growth in 2025: Rising Global Cancer In …
How Big Is the Desmoid Tumors Market Expected to Be, and What Will Its Growth Rate Be?
The desmoid tumors market is set to grow from $2.97 billion in 2024 to $3.18 billion in 2025, at a CAGR of 7.3%. Growth is driven by advancements in medical imaging, genetic research, surgical innovations, and increased awareness and education on these tumors.
The desmoid tumors market is forecast to grow strongly, reaching $4.13 billion…
Desmoid Tumors Market Strategies 2024-2033: Segments, Analysis, Trends, Opportun …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Desmoid Tumors Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.84 billion In 2028 At…
Desmoid Tumors Pipeline Outlook, Clinical Trials, FDA Approvals, and Companies 2 …
(Albany, United States) As per DelveInsight's assessment, globally, the Desmoid Tumors Pipeline constitutes 12+ key companies continuously working towards developing 12+ Desmoid Tumors Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Desmoid Tumors Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Desmoid Tumors NDA approvals (if…
